Prognostic utility of the breast cancer index and comparison to Adjuvant! Online in a clinical case series of early breast cancer

INTRODUCTION: Breast Cancer Index (BCI) combines two independent biomarkers, HOXB13:IL17BR (H:I) and the 5-gene molecular grade index (MGI), that assess estrogen-mediated signalling and tumor grade, respectively. BCI stratifies early-stage estrogen-receptor positive (ER+), lymph-node negative (LN-)...

Descripción completa

Detalles Bibliográficos
Autores principales: Jankowitz, Rachel C, Cooper, Kristine, Erlander, Mark G, Ma, Xiao-Jun, Kesty, Nicole C, Li, Hongying, Chivukula, Mamatha, Brufsky, Adam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262211/
https://www.ncbi.nlm.nih.gov/pubmed/21999244
http://dx.doi.org/10.1186/bcr3038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262211/
https://www.ncbi.nlm.nih.gov/pubmed/21999244
http://dx.doi.org/10.1186/bcr3038

Ejemplares similares